Similarly, clinical trial NCT01734915 (Detecting EGFR T790M Mutations from Circulating Tumor Cells) was initiated in 2012 and intended to assess EGFR mutations in CTCs isolated using the microfluidic CTC-chip. Here, EGFR is linked to neoplasm.